Intellia Therapeutics (NTLA) Tax Rate (2015)

Intellia Therapeutics (NTLA) posted quarterly Tax Rate of 4.48% for Q4 2015, down 47.56% quarter-over-quarter from 8.54% in Q3 2015.

Intellia Therapeutics (NTLA) Tax Rate (2015) Analysis & Trends

Intellia Therapeutics (NTLA) has reported Tax Rate for 1 consecutive years, with 4.48% the latest figure, recorded in Q4 2015.

In Q4 2015, Tax Rate changed N/A year-over-year to 4.48%; the TTM figure through Sep 2016 stood at 0.93% (changed N/A YoY), while the FY2015 annual figure was 7.55%, changed N/A from the prior year.
Tax Rate declined to 4.48% in Q4 2015 per NTLA's latest filing, from 8.54% in the prior quarter.
Across five years, Tax Rate topped out at 11.16% in Q2 2015 and bottomed at 4.48% in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Intellia Therapeutics	1.67 Bn	1.67 Bn	-	-

Download Data